Smoking cessation aids market to be contested

Competition is about to heat up in the nation's anti-smoking therapy market as some companies are going head to head for a bigger share.

Smoking is a chronic relapsing medical condition that typically involves a physical and psychological addiction to nicotine.

Pfizer Korea plans to launch Champix (varenicline), a novel pill for smoking cessation in adults. It provides a unique and new tr...